These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Outcome of kidney transplantation for renal amyloidosis:a single-center experience. Celik A, Saglam F, Dolek D, Sifil A, Soylu A, Cavdar C, Temizkan A, Bora S, Gulay H, Camsari T. Transplant Proc; 2006 Mar; 38(2):435-9. PubMed ID: 16549141 [Abstract] [Full Text] [Related]
3. Transplantation in renal amyloidosis. Türkmen A, Yildiz A, Erkoç R, Ecder T, Görçin B, Türk S, Aydin AE, Eldegez U, Ark E, Sever MS. Clin Transplant; 1998 Oct; 12(5):375-8. PubMed ID: 9787944 [Abstract] [Full Text] [Related]
4. Acute rejection episodes: best predictor of long-term primary cadaveric renal transplant survival. Tesi RJ, Elkhammas EA, Henry ML, Davies EA, Salazar A, Ferguson RM. Transplant Proc; 1993 Feb; 25(1 Pt 2):901-2. PubMed ID: 8442261 [No Abstract] [Full Text] [Related]
5. Results of renal transplantation at the Gdańsk Center. Zdrojewski Z, Rutkowski B, Lichodziejewska-Niemierko M, Debska-Slizień A, Bułło B, Gacyk W, Pirski MI, Zadrozny D, Moszkowska G. Transplant Proc; 1996 Dec; 28(6):3492-3. PubMed ID: 8962358 [No Abstract] [Full Text] [Related]
6. Kidney transplantation in patients between 65 and 75 years of age. Fehrman I, Brattstrom C, Duraj F, Groth CG. Transplant Proc; 1989 Feb; 21(1 Pt 2):2018-9. PubMed ID: 2652658 [No Abstract] [Full Text] [Related]
7. Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients. Kumano K, Irie A, Mashimo S, Endo T, Koshiba K. Transplant Proc; 1996 Jun; 28(3):1354-5. PubMed ID: 8658691 [No Abstract] [Full Text] [Related]
8. Preserving renal function and increasing graft survival in cardiac transplantation. Whiddon LL, Dickerman RM, Jett GK, Brinker KR, Vergne-Marini P, Bender P. Transplant Proc; 1991 Apr; 23(2):1778-9. PubMed ID: 2053151 [No Abstract] [Full Text] [Related]
9. The results of transplantation of patients with amyloid nephropathy. Kilicturgay S, Tokyay R, Arslan G, Bilgin N, Haberal M. Transplant Proc; 1992 Oct; 24(5):1788-9. PubMed ID: 1412844 [No Abstract] [Full Text] [Related]
10. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation. Yussim A, Shaharabani E, Mor E, Lustig S, Bar-Nathan N, Shmueli D, Sobolev V, Dorfman B, Or H, Shapira Z. Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233 [No Abstract] [Full Text] [Related]
11. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Woodle ES, Bruce DS, Josephson M, Newell KA, Piper JB, Millis JM, Cronin D, Whitman G, Ruebe M, Thistlethwaite JR. Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103 [Abstract] [Full Text] [Related]
15. [Living-donor kidney transplantation in the cyclosporine era]. Campise M, Tarantino A, Berardinelli L, Finazzi S, Montagnino G, Rossini G, Scalamogna M, Cesana B, Ponticelli C. G Ital Nefrol; 2002 Feb; 19(1):49-54. PubMed ID: 12165946 [Abstract] [Full Text] [Related]
16. Long-term results of OKT3-treated renal transplant recipients. Tanabe K, Takahashi K, Sonda K, Tokumoto T, Koga S, Nakazawa H, Goya N, Yagisawa T, Fuchinoue S, Kawai T, Toma H, Ota K. Transplant Proc; 1996 Jun; 28(3):1350-1. PubMed ID: 8658689 [No Abstract] [Full Text] [Related]
17. Risk factors for chronic rejection in renal allograft recipients. Kim HC, Suk J, Joo I, Park SB, Park KK, Cho WH, Park CH. Transplant Proc; 1996 Jun; 28(3):1456-7. PubMed ID: 8658739 [No Abstract] [Full Text] [Related]
18. OKT3 in renal allografts: survival and complications. D'Souza RJ, Kwan JT, Chang R, Bending MR. Clin Nephrol; 1999 Apr; 51(4):257-8. PubMed ID: 10230561 [No Abstract] [Full Text] [Related]